Cetera Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Sell
27,010
-150
-0.6% -$12.1K 1.15% 23
2026
Q1
$1.92M Sell
27,160
-725
-3% -$54.3K 1.09% 26
2025
Q4
$2.2M Buy
27,885
+450
+2% +$35.6K 1.18% 28
2025
Q3
$2.26M Hold
27,435
1.27% 21
2025
Q2
$2.21M Sell
27,435
-500
-2% -$38.6K 1.32% 21
2025
Q1
$2.24M Sell
27,935
-175
-0.6% -$14.6K 1.43% 21
2024
Q4
$2.3M Buy
28,110
+38
+0.1% +$3.16K 1.49% 19
2024
Q3
$2.32M Sell
28,072
-875
-3% -$65.4K 1.42% 20
2024
Q2
$2.03M Sell
28,947
-2,350
-8% -$168K 1.28% 25
2024
Q1
$2.32M Sell
31,297
-850
-3% -$59.2K 1.4% 23
2023
Q4
$2.13M Buy
+32,147
New +$2.01M 1.32% 27

Other funds holding MET

Cetera Trust Company's MET Position: Q2 2026 in Review

Cetera Trust Company reduced its MetLife (MET) stake by 0.55% in Q2 2026, selling an estimated $12.1K and leaving 27,010 shares worth $2.29M. The position accounts for 1.15% of the portfolio, ranked #23.

Cetera Trust Company first reported a position in MET in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.32M in Q1 2024. 1,446 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Cetera Trust Company held 27,010 shares of MetLife worth $2.29M as of Q2 2026.
  • Cetera Trust Company sold 150 MetLife shares in Q2 2026, an estimated $12.1K.
  • MetLife made up 1.15% of Cetera Trust Company's portfolio in Q2 2026, its #23 holding.
  • Cetera Trust Company first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's MetLife position peaked at $2.32M in Q1 2024.
  • 1,446 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.